APOE and Alzheimer disease: The observed differences in ERC-FC between APOE ε4 carriers and non-carriers may reflect early changes in functional brain organization associated with AD pathology, which may eventually lead to the cognitive decline observed in APOE ε4 carriers [40, 41].